7BA

Combretastatin A4

Created:	2016-09-28
Last modified:	2017-01-18

Find Related PDB Entry
1 entries where 7BA is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	43
Chiral Atom Count	0
Bond Count	44
Aromatic Bond Count	12

2D diagram of 7BA

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	Combretastatin A4
Systematic Name (OpenEye OEToolkits)	2-methoxy-5-[(~{Z})-2-(3,4,5-trimethoxyphenyl)ethenyl]phenol
Formula	C₁₈ H₂₀ O₅
Molecular Weight	316.348
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	COc1ccc(C=Cc2cc(OC)c(OC)c(OC)c2)cc1O
SMILES	OpenEye OEToolkits	2.0.6	COc1ccc(cc1O)C=Cc2cc(c(c(c2)OC)OC)OC
Canonical SMILES	CACTVS	3.385	COc1ccc(\C=C/c2cc(OC)c(OC)c(OC)c2)cc1O
Canonical SMILES	OpenEye OEToolkits	2.0.6	COc1ccc(cc1O)/C=C\c2cc(c(c(c2)OC)OC)OC
InChI	InChI	1.03	InChI=1S/C18H20O5/c1-20-15-8-7-12(9-14(15)19)5-6-13-10-16(21-2)18(23-4)17(11-13)22-3/h5-11,19H,1-4H3/b6-5-
InChIKey	InChI	1.03	HVXBOLULGPECHP-WAYWQWQTSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB14680
Name	Combretastatin A4
Groups	investigational experimental
Synonyms	Combretastatin 4 Combretastatin A-4 PHENOL, 2-METHOXY-5-(2-(3,4,5-TRIMETHOXYPHENYL)ETHENYL)-, (Z)- 2'-deoxycombretastatin A1 CA4 Combrestatin A4 Combretastatin A4
Categories	Antineoplastic Agents Antineoplastic Agents, Phytogenic Benzene Derivatives Benzylidene Compounds
CAS number	117048-59-6

Related Resource References

Resource Name	Reference
Pharos	CHEMBL67
PubChem	5351344
ChEMBL	CHEMBL67
CCDC/CSD	TIJYER02, TIJYER01, TIJYER
COD	2022251, 2022250

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.